|
|
 |
|
Viewing report
|
|
|
|
India: Pharmaceutical
Internet Securities Inc, June 2008, Pages: 20
In 2006, India ranked 12th in the global pharmaceutical market in dollar terms with a market share of 1.27% globally. It was estimated that India’s pharmaceutical industry is worth USD 8.8 billion in 2005. Indian companies continue to dominate the generic market with a total market share of 70% in 2006. Meanwhile, India’s pharmaceutical industry accounted for approximately 21% of the global DMFs. India has 75 US FDA approved plants, the highest number of US FDA approved plants outside US.
Apart from the relatively low development cost and skilled manpower, the availability of raw materials at competitive prices makes India a preferred manufacturing hub for pharmaceutical giants. Another obvious reason is its IT prowess. As pharmacy research becoming more and more IT oriented, India is in a position to leverage on its strong IT base. India is also emerging as an important destination for global pharmaceutical companies, which are increasingly considering outsourcing and off shoring their drug discovery, research and development, and clinical research.
Customers who bought this item also bought
India: Pharmaceutical and biotechnology opportunities
India: Pharmaceutical
Indian Pharmaceutical Industry: Issues and Opportunities
Pharmaceutical Outsourcing in Drug Discovery and Development: Contract Research Opportunity in India
The Indian Pharmaceutical Industry: Expansion & Ambitions + Indian Pharma Industry Tracker
The Indian Pharmaceutical Industry: Expansion & Ambitions
The World Generic Market Report 2008
Analyzing the Global Pharmaceutical Industry
|
|
|
|
